ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study

Ye, Yanna; Zhang, Guozhao; Li, Zhiqiang; Chen, Biliang; Zhao, Hongwei; Yang, Ying; Wang, Li; Yao, Jilong; Chen, Xiaolin; Huang, Yahong; Lang, Jinghe; Liu, Ping*; Chen, Chunlin*东莞理工学院; 南方医科大学; 郑州大学; 中国医学科学院北京协和医院
Cancer Medicine2023-10DOI: 10.1002/cam4.6586
7阅读
引用收藏
分享

摘要

Background: To compare the oncological outcomes of radical chemotherapy (R-CT), abdominal radical hysterectomy (ARH), and neoadjuvant chemotherapy and radical surgery (NACT) for International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIIC cervical cancer, according to histological types: squamous cell carcinoma (SCC) and adenocarcinoma (AC)/adenosquamous cell carcinoma (ASC).Methods: A comparison of 5-year overall survival (OS) and disease-free survival (DFS) was performed for the SCC and AC/ASC subgroups for the three initial treatments, assessed using Kaplan-Meier and Cox proportional hazards regression analysis and validated using propensity score matching (PSM).Results: The study included 4086 patients: R-CT, n = 1913; ARH, n = 1529; and NACT, n = 644. AC/ASC had a lower survival rate (63.7%) than SCC (73.6%) and a higher recurrence and mortality rate (36.3% and 26.4%, respectively). The 5-year OS and DFS rates were different in the SCC group for R-CT, ARH, and NACT (OS: 69.8% vs. 80.8% vs. 73.0%, p < 0.001; DFS: 66.7% vs. 70.7% vs. 56.4%, p < 0.001), also in the AC/ASC group (OS: 46.1% vs. 70.6% vs. 55.6%, p < 0.001; DFS: 42.7% vs. 64.6% vs. 40.8%, p < 0.001). As for initial treatment, survival outcomes were worse for AC/ASC treated with R-CT and ARH than for SCC (both p < 0.05), with no group differences between the two treated with NACT.Conclusion: Initial treatment influences oncological prognosis for patients with FIGO 2018 stage IIIC cervical cancer. ARH is an alternative treatment for stage IIIC cervical SCC and AC/ASC, and NACT needs to be chosen with caution, moreover, R-CT for AC/ASC requires careful selection.

学科与关键词

关键词
adenocarcinoma/adenosquamous cell carcinomacervical cancercervical cancer treatmentsquamous cell carcinomastage IIIC cervical cancer
相关
加载中…
  • Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
    Ye, Yanna; Li, Zhiqiang; Kang, Shan; Yang, Yongxiu; Ling, Bin; Wang, Li; Yao, Jilong; Li, Pengfei; Wang, Xueqin; Gong, Shipeng; Fan, Huijian; Kong, Yanxiang; Cao, Yuye; Lang, Jinghe; Liu, Ping*; Chen, Chunlin*BMC CANCER, 2023, 23(1): 421.
  • Abdominal Radical Hysterectomy as an Alternative Treatment Option for Patients with Cervical Cancer without Access to Radiotherapy Facilities
    Ye, Yanna; Li, Zhiqiang; Chen, Biliang; Kang, Shan; Ling, Bin; Wang, Li; Yao, Jilong; Lan, Jinghe; Liu, Ping*; Chen, Chunlin*Clinical and Experimental Obstetrics & Gynecology, 2023, 50(10): 5010219.
  • Discussion on the Treatment Strategy for Stage IIA1 Cervical Cancer (FIGO 2018)
    Chen, Xiaolin; Liang, Wentong; Duan, Hui; Wu, Minling; Zhan, Xuemei; Dai, Encheng; Lv, Qiubo; Xie, Qinghuang; Liu, Ruilei; Xu, Yan; Bin, Xiaonong; Lang, Jinghe; Liu, Ping*; Chen, Chunlin*Frontiers in Oncology, 2022, 12: 800049.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Medicine
发表日期
2023-10
卷期
第 12 卷, 第 19 期
页码
19617-19632
DOI
10.1002/cam4.6586
语言
ENGLISH
成果收录
SCIE
资助标注
We thank Min Hao (The Second Hospital of Shanxi Medical University), Bin Ling (China-Japan Friendship Hospital), Lixin Sun and Hongwei Zhao (Shanxi Cancer Hospital), Jihong Liu and Lizhi Liang (Sun Yat-sen University Cancer Center), Lihong Lin and Yu Guo (; (Second Hospital of Shanxi Medical University) [153]; (Institute of Guangzhou Medical University) [988]; Center Hospital of the Liberation Army/Hospital

作者

  • Y

    Ye, Yanna (第一作者)

    southern med univ · dongguan polytech

  • Z

    Zhang, Guozhao

    china japan friendship hosp

查看全部 13 位作者收起作者
  • L

    Li, Zhiqiang

    southern med univ

  • C

    Chen, Biliang

  • Z

    Zhao, Hongwei

    shanxi prov canc hosp

  • Y

    Yang, Ying

    xinqiao hosp

  • W

    Wang, Li

    zhengzhou univ

  • Y

    Yao, Jilong

  • C

    Chen, Xiaolin

    southern med univ

  • H

    Huang, Yahong

    southern med univ

  • L

    Lang, Jinghe

    peking union med coll hosp · southern med univ

  • L

    Liu, Ping (通讯)

    southern med univ

  • C

    Chen, Chunlin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417